Your browser doesn't support javascript.
loading
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Kern, Wolfgang; Westers, Theresia M; Bellos, Frauke; Bene, Marie Christine; Bettelheim, Peter; Brodersen, Lisa Eidenschink; Burbury, Kate; Chu, Sung-Chao; Cullen, Matthew; Porta, Matteo Della; Dunlop, Alan Stewart; Johansson, Ulrika; Matarraz, Sergio; Oelschlaegel, Uta; Ogata, Kiyoyuki; Porwit, Anna; Preijers, Frank; Psarra, Katherina; Saft, Leonie; Subirá, Dolores; Weiß, Elisabeth; van der Velden, Vincent H J; van de Loosdrecht, Arjan.
Afiliação
  • Kern W; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Westers TM; Department of Hematology, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Bellos F; MLL Munich Leukemia Laboratory, Munich, Germany.
  • Bene MC; Hematology Biology, Nantes University Hospital, Nantes, France.
  • Bettelheim P; Department of Hematology, Elisabethinen Hospital, Linz, Upper Austria, Austria.
  • Brodersen LE; Hematologics, Inc., Seattle, Washington, USA.
  • Burbury K; Peter MacCallum Cancer Centre, Melbourne, Australia.
  • Chu SC; Department of Hematology and Oncology, Buddhist Tzu Chi General Hospital, Hualien, Taiwan.
  • Cullen M; Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
  • Porta MD; Department of Biomedical Sciences, IRCCS Humanitas Research Hospital, Humanitas University, Milan, Italy.
  • Dunlop AS; Department of Haematology, College Hospital London, London, England.
  • Johansson U; Laboratory Medicine, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Matarraz S; Cytometry Service (NUCLEUS), Department of Medicine and IBSAL, Cancer Research Center (IBMCC, University of Salamanca-CSIC), Salamanca, Spain and Centro de Investigación Biomédica en Red de Cáncer (CIBERONC), Salamanca, Spain.
  • Oelschlaegel U; Department of Internal Medicine, University Hospital of Technical University Dresden, Dresden, Germany.
  • Ogata K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan.
  • Porwit A; Division of Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
  • Preijers F; Department of Laboratory Medicine, Laboratory of Hematology, Radboudumc, Nijmegen, The Netherlands.
  • Psarra K; Immunology Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
  • Saft L; Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital and Institute, Stockholm, Sweden.
  • Subirá D; Department of Medical Immunology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Weiß E; MLL Munich Leukemia Laboratory, Munich, Germany.
  • van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • van de Loosdrecht A; Department of Hematology, Amsterdam University Medical Centers, VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
Cytometry B Clin Cytom ; 104(1): 51-65, 2023 01.
Article em En | MEDLINE | ID: mdl-36416672

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Leucemia Mielomonocítica Crônica Tipo de estudo: Clinical_trials / Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cytometry B Clin Cytom Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Alemanha